Piper Jaffray Trims PT on Veracyte (VCYT) to $12, Maintains 'Overweight'

August 14, 2015 7:33 AM

Piper Jaffray analyst William Quirk reiterated an Overweight rating but trimmed his price target on Veracyte, Inc (NASDAQ: VCYT) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found